Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Status:
Completed
Trial end date:
2013-05-09
Target enrollment:
Participant gender:
Summary
This is a 36 week open-label extension of the canakinumab pre-filled syringe study for safety
and tolerability in patients who have frequent flares of acute gouty arthritis.